Literature DB >> 9573024

Biologically active Fas antigen and its cognate ligand are expressed on plasma membrane-derived extracellular vesicles.

J Albanese1, S Meterissian, M Kontogiannea, C Dubreuil, A Hand, S Sorba, N Dainiak.   

Abstract

Exfoliation of plasma membrane components is a directed process that consumes energy and requires active cell metabolism. Proteins involved in regulating the survival and proliferation of eukaryotic cells are released on exfoliated vesicles. We examine here whether the Fas receptor and its cognate ligand (FasL) are present on vesicles shed from high metastatic potential CX-1 cells and low metastatic potential MIP-101 cells and from HuT 78 cells, respectively. Rates of exfoliation at 2 hours and cumulative levels of extracellular vesicles in serum-free medium conditioned by CX-1 cells are increased by 1.8-fold and 1.6-fold, respectively, relative to that in medium conditioned by MIP-101 cells. Although vesicles shed from both cancer cell lines contain Fas antigen, the amount of Fas per vesicle and the percentage of vesicles containing Fas are increased for vesicles isolated from MIP-101 cells, relative to those from CX-1 cells, as determined by immunogold particle labeling and electron microscopy and by immunofluorescence microscopy and flow cytometry. Results of metabolic labeling with 35S-methionine indicate that Fas biosynthesis is reduced by up to 3.3-fold for CX-1 cells, relative to that of MIP-101 cells, consistent with the finding of decreased Fas on vesicles shed from the plasma membrane of CX-1 cells. Although mRNA for soluble Fas receptor is detectable in both cell lines, depletion of shed vesicles from serum-free medium by ultracentrifugation removes all detectable biological activity. FasL is detected on vesicles exfoliated from HuT 78 cells by immunoelectron microscopy and Western blot analysis. FasL-bearing vesicles induce apoptosis of Fas-expressing cancer cells at the same level as observed by treatment with monoclonal anti-Fas antibody. Furthermore, Fas-bearing extracellular vesicles from MIP-101 but not from CX-1 cells protect the CX-1 cell line from FasL-induced and anti-Fas-mediated apoptosis, indicating that Fas present on shed vesicles is biologically active. We conclude that the Fas antigen and its cognate ligand are exfoliated from the cell surface in a bioactive configuration. Exfoliation may provide a mechanism for long-range signal-directed apoptosis while maintaining Fas/FasL on a membrane surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573024

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

2.  Testicular FasL is expressed by sperm cells.

Authors:  A D'Alessio; A Riccioli; P Lauretti; F Padula; B Muciaccia; P De Cesaris; A Filippini; S Nagata; E Ziparo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Potential for new medical countermeasures for radiation injury by targeting the Hedgehog signaling pathway.

Authors:  N Dainiak
Journal:  Bone Marrow Transplant       Date:  2014-03       Impact factor: 5.483

Review 4.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

Review 5.  The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies.

Authors:  David Wallach
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

Review 6.  Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.

Authors:  Douglas D Taylor; Cicek Gercel-Taylor
Journal:  Semin Immunopathol       Date:  2011-06-19       Impact factor: 9.623

7.  Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo.

Authors:  Ferdinando Pucci; Mikael J Pittet
Journal:  Clin Cancer Res       Date:  2013-02-20       Impact factor: 12.531

8.  Serum soluble MICB (sMICB) correlates with disease progression and survival in melanoma patients.

Authors:  Bao-Jin Wu; Wen-Peng Li; Cheng Qian; Wei Ding; Zhong-Wen Zhou; Hua Jiang
Journal:  Tumour Biol       Date:  2012-11-14

Review 9.  The role of microparticles in the pathogenesis of rheumatic diseases.

Authors:  Christian Beyer; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2009-12-01       Impact factor: 20.543

10.  Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles.

Authors:  Ilaria Giusti; Sandra D'Ascenzo; Danilo Millimaggi; Giulia Taraboletti; Gaspare Carta; Nicola Franceschini; Antonio Pavan; Vincenza Dolo
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.